The Inflammasome Pathway as a Key Positive Regulator of HIT Pathology – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by James Michael et al, adding:
”Heparin-Induced Thrombocytopenia Immune Complexes Activate the Inflammasome Pathway in a Complement-Dependent Manner
This study demonstrates that HIT immune complexes trigger NLRP3 inflammasome activation and IL-1β secretion via FcγRIIA and complement-dependent signaling in both human blood and transgenic mouse models, identifying the inflammasome pathway as a key positive regulator of HIT pathology. ”
Title: Heparin-induced thrombocytopenia immune complexes activate the inflammasome pathway in a complement-dependent manner
Authors: James Michael, Sanjay Khandelwal, Antonios Tawk, MD, MSc, Sophia Lazar, Christopher Garren Hester, Trenton G. Hiatt, Gowthami M. Arepally, Steven McKenzie
Stay updated on all scientific advances with Hemostasis Today.
-
May 9, 2026, 14:17Anna Gardin: Incredible Initiative to Measure Clinician’s Own Lp(a) On The Spot at ESOC 2026
-
May 9, 2026, 14:10Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
-
May 9, 2026, 14:00Dorcas Gandhi: Telerehabilitation, Low-Cost Robotics in India and AVERT-DOSE Results at ESOC 2026
-
May 9, 2026, 13:50Khaled Musallam: Listening to Patients’ Needs and Challenges Remains the Foundation for a Better Care
-
May 9, 2026, 13:43Matías J Alet: Proud to Present the CAMINA Project on Argentina’s National Stroke Center Mapping at ESOC 2026
-
May 9, 2026, 13:28Maeva May: Stroke Association Is Proud to Support WHO Resolution on Global Stroke Advocacy
-
May 9, 2026, 11:44Somia Iqtadar։ A Meeting with the Scientist Who Helped Transform Anticoagulation
-
May 9, 2026, 11:33Awa Babington-Ashaye: WFH Congress Reflections on Access AI and Patient Care
-
May 9, 2026, 11:23Dirk Sibbing: Why CYP2C19 Genetics Matter in Clopidogrel Response